The present study was designed to reveal protein modifications in control cases related with postmortem delay and temperature of storage in 3 paradigms in which the same postmortem tissue sample (frontal cortex) was frozen a short time after death or stored at 1-C, 4-C, or room temperature and then frozen at j80-C at different intervals. No evidence of protein degradation as revealed with monodimensional gel electrophoresis and Western blotting was observed in samples artificially stored at 1-C and then frozen at different intervals up to 50 hours after death. However, the levels of several proteins were modified in samples stored at 4-C and this effect was more marked in samples stored at room temperature. Two-dimensional gel electrophoresis and mass spectrometry further corroborated these observations and permitted the identification of other proteins vulnerable or resistant to postmortem delay. Finally, gel electrophoresis and Western blotting of sarkosyl-insoluble fractions in Alzheimer disease showed reduced intensity of phospho-tau-specific bands with postmortem delay with the effects being more dramatic when the brain samples were stored at room temperature for long periods. These results emphasize the necessity of reducing the body temperature after death to minimize protein degradation.
INTRODUCTION
Although several experimental approaches and animal models have been used to mimic situations occurring in human degenerative diseases of the nervous system, the direct study of human brain tissue is crucial to increasing our understanding of real human neurodegenerative disorders. Optimal material quality is, however, a determining condition to avoid pitfalls related to tissue obtained at postmortem under suboptimal conditions. Many factors can affect the preservation of brain tissue before and after death. Premortem, the most relevant factors are the metabolic state, the use of toxic substances and drugs, infections, seizures, and hypoxia. Moreover, their detrimental effects can be augmented by a prolonged agonal state. At postmortem, delay among brain extraction, storage and tissue processing, as well as environmental temperature, are the most critical factors (1) . Because the 2 last factors are the easiest to control, we have focused our study on postmortem delay and temperature to determine their relevance in the degree of preservation and degradation of brain proteins. This is an important issue because protein expression levels, as revealed by gel electrophoresis and Western blotting, are currently used in studies of human diseases of the nervous system.
One-time studies with human brain tissue have shown the importance of assessing the effects of postmortem delay on the preservation of target proteins. According to these observations, it has been shown that some proteins are very resistant to postmortem delay, whereas others are not. For example, Li et al studied the effects of postmortem delay (between 5 and 21 hours) in the expression levels of G-proteins in human prefrontal cortex (2) . Under the same conditions, G>-i1, G>-i2, G>-S, and GA were stable, whereas G>-q and G>-o were vulnerable to postmortem delay. Similarly, Siew et al, focusing on the expression of pre-and postsynaptic proteins in the rat cerebral cortex at Copyright @ 2006 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited. different intervals postmortem, showed that synaptophysin and PSD-95 remained stable throughout the period studied, whereas the expression levels of syntaxin decreased at 48 hours when the brain was stored at room temperature and at 72 hours when the brain was maintained at 4-C (3). Similar results were obtained when examining the effects of postmortem delay and temperature on selected synaptic proteins by immunohistochemistry (4) . Delayed tissue processing after death results in variable modifications in the expression levels of the microtubule-associated proteins tau, MAP2, MAP1B, and MAP5 (5, 6) . Nucleosides in the brain are also subject to postmortem degradation (7) .
Effects of postmortem delay are also important when studying posttranslational modifications in certain human degenerative diseases as hyperphosphorylated tau band profiles in sarkosyl-insoluble fractions in Alzheimer disease (AD) and other tauopathies (8, 9) . Modifications in the expression levels of phosphorylated proteins may be related to the presence of still active proteases and phosphatases in the postmortem brain (10, 11) .
The present BrainNet Europe study concerning preservation trials was designed to reveal protein modifications in human postmortem brains in several paradigms. For this purpose, the same tissue sample was frozen shortly after death or stored at 1-C, 4-C, or at room temperature for varying time periods and then frozen at j80-C until use. The samples were analyzed by gel electrophoresis and Western blotting with a battery of antibodies including synapsis-related proteins, kinases, proteins of the cytoskeleton, trophic factor receptors, membrane protein, protein related with oxidative stress, protein associated with apoptotic pathway, and members of the ubiquitin proteasome system. The selection of these proteins was made at random to represent a varied range of proteins that can be possible targets for study in human diseases of the nervous system. Other samples were analyzed by bidimensional (2D) gel electrophoresis, in-gel digestion, and mass spectrometry. This permitted the identification of other proteins vulnerable to postmortem delay. Finally, the effects of postmortem delay on posttranslational modifications related to tau hyperphosphorylation in tauopathies were examined by gel electrophoresis and Western blotting of sarkosyl-insoluble fractions in cases with Alzheimer disease. Because it has been reported that another source of variation in the postmortem vulnerability of certain proteins is as a result of their regional location in the brain (3), the present study focused on human brain frontal cortex to eliminate possible regional bias.
MATERIALS AND METHODS

Human Brain Tissue
Protein preservation was examined in several paradigms that try to mimic postmortem delay degradation in the human brain. Review of clinical records and general autopsy reports revealed that all patients showed minimal evidence of prolonged agonal state. No evidence of neurologic disease, drug intake, or metabolic disease was noticed. The patients studied included 3 men and one woman. The age at death was 68, 66, 65, and 63 years, and the cause of death was heart failure in 3 cases and pneumonia in the fourth. The brains were obtained for research after written consent from the relatives following the guidelines of the local ethics committee of the IDIBELL-Hospital Universitari de Bellvitge. In all cases, half of the brain was stored in 4% paraformaldehyde in phosphate buffer for 3 weeks and then processed for the current neuropathologic study. The other half of the brain, except the frontal lobe, was immediately cut in coronal sections, frozen, and stored at j80-C. Part of the left frontal lobe, including Brodmann areas 8, 9, 45, and 46, was used for the present study. The basal pH of the brain tissue was 6.8, 7.2, and 6.9 in the 4 cases.
Finally, the frontal cortex (areas 8) of 4 cases with AD stage VI/C according to Braak and Braak was used in the study of phospho-tau degradation in relation to postmortem delay (12) . AD cases were 2 men and 2 women aged 72, 68, 78, and 81 years. The neuropathologic diagnosis was carried out using the same regions and methods as described previously.
Paradigms Mimicking Delayed Postmortem Delay; Modifications of Storage Time and Ambient Temperature
In case 1, samples were obtained and frozen 2 hours after death or stored for 3, 6, 21, and 48 hours (i.e. 5, 8, 23 , and 50 hours of postmortem delay) at 4-C and then frozen at j80-C. In case 2, samples were obtained and frozen 2 hours and 15 minutes after death or stored for 2 hours 45 minutes, 5 hours 45 minutes, 13 hours 45 minutes, 22 hours 45 minutes, and 48 hours (i.e. 5, 8, 16, 23 , and 50 hours of postmortem delay) at 1-C and then frozen at j80-C. In case 3, samples were obtained and frozen 2 hours after death or stored for 3, 6, 21, and 48 hours (i.e. 5, 8, 23 , and 50 hours of postmortem delay) at room temperature (23-C) and then frozen at j80-C. In case 4, samples were obtained and frozen 2 hours after death or stored for 3, 6, 22, and 46 hours (i.e. 5, 8, 24 , and 48 hours of postmortem delay) at room temperature (22-C) and then frozen at j80-C.
Regarding AD cases, the brains were obtained 2 hours after death in 2 cases (cases AD1 and AD2) and the samples of the left frontal cortex were rapidly frozen at j80-C or stored at room temperature for different time periods and then frozen at 5, 8, 26 , and 50 hours after death. Another case (case AD3) was obtained at 6 hours after death and then frozen or stored at room temperature for different time periods and then frozen at 8, 12, 18, 24, and 48 hours after death. The fourth case (case AD4) was obtained 8 hours after death and then frozen. Later, part of the sample was thawed and pieces were maintained at room temperature until 12, 18, 24, and 48 hours after death and then frozen until use. In every case, the blocks were wrapped in normal kitchen aluminum foil and maintained at room temperature in a plastic box with appropriate humidity conditions until frozen.
Biochemical Studies
Frontal cortex homogenates at the different time points in the first 3 paradigms were subjected to monodimensional gel electrophoresis and Western blotting. Twenty-three antibodies recognizing specific proteins were analyzed. These antibodies included proteins involved in the cytoskeleton and synapses, membrane proteins, trophic factors and their receptors, proteins involved in cell survival and cell death, and transcription factors (Table 1) . Every sample was processed per triplicate on different days.
In addition, the same tissue samples were examined in several human brain banks: Milan, Vienna, Munich, Edinburgh, and Bologna. Western blotting was restricted to 4 proteins (AKT-P, CaM kinase II, A-actin, and >-tubulin) in these laboratories. The antibodies were provided by the laboratory of reference so that the same aliquots were used by the different partners.
Bidimensional gel electrophoresis of the first, second, and fourth case was carried out in Barcelona. Finally, monodimensional gel electrophoresis and Western blotting of sarkosyl-insoluble fractions was carried out in the 4 cases with AD in Barcelona.
Monodimensional Gel Electrophoresis and Western Blotting
Brain samples (0.2 g) were homogenized separately in a glass homogenizer in 1 mL of homogenizer Buffer (10 mM Tris-HCl pH 7.4, 100 mM NaCl, 10 mM EDTA, 0.5% sodium deoxycholate, and 0.5% NP40) and complete protease inhibitor cocktail (Roche Molecular Systems, Madrid, Spain). After a brief centrifugation at 15,000 rpm (4-C for 5 minutes), the pellet was discarded and the concentration of the resulting supernatant was determined by the bicinchoninic acid (BCA) method with bovine serum albumin as a standard.
For Western blot studies, 30 Kg was mixed with reducing sample buffer and processed for 10% SDS-PAGE electrophoresis and then transferred to nitrocellulose membranes (400 mA, 90 minutes). Immediately afterward, the membranes were incubated with 5% skimmed milk in TBS-T buffer (100 mM Tris-buffered saline, 140 mM NaCl, and 0.1% Tween 20, pH 7.4) for 30 minutes at room temperature and then incubated with the primary antibody in TBS-T containing 3% BSA (Sigma, Madrid, Spain) at 4-C overnight. The characteristics of the primary antibodies are given in Table 1 .
Subsequently, the membranes were incubated for 45 minutes at room temperature with the corresponding secondary antibody labeled with horseradish peroxidase (Dako, Madrid, Spain) at a dilution of 1:1000 and washed 
Densitometry and Processing of Data
Protein expression levels were determined by densitometry of the specific bands using Total Lab v2.01 software (Pharmacia, Orsay, France). The results were normalized for Aactin. The numeric data obtained per triplicate for every protein at a given time period were expressed as a percentage of decrease compared with the corresponding basal (2-hour) values.
Two-Dimensional Gel Electrophoresis
Samples of the frontal cortex (0.1 g) were homogenized in homogenizer buffer (50 mM Tris pH 7.4 containing 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, and a cocktail of protease and phosphatase inhibitors) and centrifuged at 15,000 rpm for 5 minutes. The pellet was discarded and the concentration of protein from the resulting supernatant was determined by BCA method. Equal amounts of protein were mixed with a buffer containing, at final concentrations, 40 mM Tris pH 7.5, 7 M urea, 2 M thiourea 0.2% Biolite (v/v), 4% CHAPS (BioRad, Barcelona, Spain), 2 mM Tributylphosphine solution, and bromophenol blue in a total volume of 350 KL.
In the first dimension electrophoresis, 350 KL of sample solution was applied on an immobilized 17-cm pH 3Y10 nonlinear gradient ReadyStrip IPG strip (Bio-Rad, Barcelona, Spain) at both the basic and acidic ends of the strip. The strips were actively rehydrated for 16 hours at 50 V and the proteins were focused at 300 V for 2 hours after which time the voltage was gradually increased over 4 hours to 1,000 V. Focusing was continued at 1,000 V for 2 hours and gradually increased to 8,000 V over 8 hours; it then continued at 8,000 V for 10 hours. For the second dimension separation, IPG strips were equilibrated for 15 minutes in 50 mM Tris-HCl (pH 6.8) containing 6 M urea, 2% (wt/v) SDS, 30% (v/v) glycerol, and 2% dithiotreitol and then reequilibrated for 15 minutes in the same buffer containing 2.5% iodoacetamide. The strips were placed on 10% polyacrylamide gels and electrophoresed at 50 V overnight. For gel staining, an MS-modified silver staining method (Amersham) was used as described by the manufacturer.
In-Gel Digestion
Proteins were in-gel-digested with trypsin (Sequencing grade modified; Promega, Barcelona, Spain) in the automatic Investigator ProGest robot of Genomic Solutions. Briefly, excised gels spots were washed sequentially with ammonium bicarbonate buffer and acetonitrile. Proteins were reduced and alkylated for 30 minutes with 10 mM DTT solution and 100 mM solution of iodine acetamide, respectively. After sequential washings with buffer and acetonitrile, proteins were digested overnight at 37-C with trypsin 0.27 nM. Tryptic peptides were extracted from the gel matrix with 10% formic acid and acetonitrile. The extracts were pooled and dried in a vacuum centrifuge.
Acquisition of MS and MS/MS Spectra
Proteins manually excised from the 2D gels were digested and analyzed by CapLC-nano-ESI-MS-MS mass spectrometry. The tryptic digested peptide samples were analyzed using on-line liquid chromatography (CapLC; Micromass-Waters, Beverly, MA) coupled to tandem mass spectrometry (Q-TOF Global; Micromass-Waters). Samples were resuspended in 12 KL of 10% formic acid solution, and 4 KL was injected for chromatographic separation into a reverse-phase capillary C 18 column (75 Km of internal diameter and 15 cm in length, PepMap column; LC Packings, Sunnyvale, CA). The eluted peptides were ionized through coated nano-ES needles (PicoTip; New Objective, Woburn, MA). A capillary voltage of 1,800 to 2,200 V was applied together with a cone voltage of 80 V. The collision in the collision-induced dissociation was 25 to 35 eV, and argon was used as the collision gas. Data were generated in PKL file format and submitted for database searching in MASCOT server (Matrix Science, Boston, MA) using the NCBI database with the following parameters: trypsin enzyme, one missed cleavage, carbamidomethyl C as fixed modification and oxized (M) as variable modification, and mass tolerance of 150 to 250 ppm. Probability-based MOWSE score was used to determine the level of confidence in the identification of specific isoforms from the mass spectra. This probability equals 10 (-MOWSE score/10) . MOWSE scores greater than 48 were considered to offer high confidence of identification.
Gel Electrophoresis and Western Blotting of Sarkosyl-Insoluble Fractions in Alzheimer Disease
Frozen samples of approximately 2 g from the frontal cortex (area 8) were gently homogenized in a glass tissue grinder in 10 vol (w/v) with cold suspension buffer (10 mM TRIS-HCl, pH 7.4, 0.8 M NaCl, 1 mM EGTA, 10% sucrose). The homogenates were first centrifuged at 20,000 rpm and the supernatant (S1) was retained. The pellet was rehomogenized in 5 vol of homogenization buffer and recentrifuged. The 2 supernatants (S1 and S2) were then mixed and incubated with 0.1% N-lauroylsarcosinate (sarkosyl) for 1 hour at room temperature while being shaken. Samples were then centrifuged at 100,000 rpm in a Ti70 Beckman rotor. Sarkosyl-insoluble pellets (P3) were resuspended (0.2 mL/g starting material) in 50 mM TRIS-HCl (pH 7.4). Protein concentrations were determined with the BCA method. Equal amounts of protein (75 Kg) were loaded on to 10% sodium dodecylsulfate polyacrylamide gel electrophoresis and then electrophoretically transferred to nitrocellulose membranes (Hybond-C Extra; Amersham) at 400 mA/gel at 4-C. The membranes were blocked for 1 hour at room temperature with 5% nonfat dry milk in Trisbuffered saline containing 0.1% Tween 20 (TTBS) and were then incubated with rabbit polyclonal phosphospecific antibodies to tauSer422 (Calbiochem, La Jolla, CA). After washing with TTBS, blots were incubated with anti-rabbit IgG conjugated with horseradish peroxidase 1:1000 (Dako) for 45 minutes at room temperature. Immunoreactive bands were visualized by chemiluminescence using the ECL method (Amersham).
RESULTS
Monodimensional Gel Electrophoresis and Western Blotting Samples Stored at 4-C and Then Frozen
Monodimensional gel electrophoresis and Western blotting in case 1 (samples obtained and frozen at 2 hours (basal values) or stored at 4-C and then frozen at 5, 8, 16, 23, and 50 hours after death showed variable patterns of protein preservation with time (Fig. 1) . Some proteins were vulnerable, particularly after 23 hours, whereas others remained practically unaffected at 50 hours. The most resistant proteins were A-actin, p38-P, proteasome 20, and proteasome 11. These proteins were considered suitable for the control of protein loading, and A-actin in particular was used for densitometric studies. Therefore, densitometric values for a given protein were normalized for the corresponding values of A-actin. Examples of the diagrams and densitometric values are shown in Figure 2 .
For comparative purposes, proteins were categorized according to the percentage of reduction of the densitometric intensity normalized for A-actin through time of postmortem. Data are summarized as follows: 1) proteins with no reduction at 23 and 50 hours when compared with basal values: p38-P, proteasome 11, A-actin, and proteasome 20S; 2) proteins with a percentage of reduction between 30% and 50% of basal values at 50 hours: SAPK/JNK-P, syntaxin, >-tubulin, and Fyn K; 3) proteins with a percentage of reduction between 60% and 90% from control values at 50 hours: Mek 1, rabphilin, >-synuclein, P-MAPK-ERK44/ERK42, rab3a, AKT-P, A-tubulin, CamK II, Cdk5, EGF-R, TrkB, Bcl-2, GSK Ser9, iNOS, and PLC A1; and 4) percentage of reduction between 40% and 60% at 23 hours: Mek 1, P-MAPK/ERK 44, AKT-P, CamK II, Cdk5, TrkB, Bcl-2, and iNOS.
Interestingly, the expression levels of all the proteins examined were preserved at 5 and 8 hours when compared 
Samples Stored at 1-C and Then Frozen
No modifications in staining were observed in the frontal samples of case 2 obtained and frozen 2 hours and 15 minutes after death (basal values) or stored for 2 hours 45 minutes, 5 hours 45 minutes, 22 hours 45 minutes, and 48 hours (i.e. 5, 8, 23, and 50 hours of postmortem delay) at 1-C, and then frozen at j80-C. Like in the previous paradigm, densitometric studies for every protein were normalized for A-actin.
Samples Stored at Room Temperature (23-C) and Then Frozen
Monodimensional Gel Electrophoresis and Western Blotting in Cases 3 and 4
Samples were obtained and frozen at 2 hours (basal values) or stored at 23-C and then frozen at 5, 8, 23, and 50 hours after death showed more severe patterns of protein degradation with time. All proteins examined except proteasome components were reduced at 50 hours. Data are summarized as follows: 1) proteins with no reduction at 23 hours when compared with basal values: p38-P, proteasome 11, A-actin, and proteasome 20S; 2) proteins with a percentage of reduction between 30% and 50% of basal values at 23 hours: SAPK/JNK-P, syntaxin, >-tubulin, Fyn K, and >-synuclein; 3) proteins with a percentage of reduction between 60% and 90% from control values at 23 hours: Mek 1, rabphilin, >-synuclein, P-MAPK-ERK44/ERK42, rab3a, AKT-P, A-tubulin, CamK II, Cdk5, EGF-R, TrkB, Bcl-2, GSK Ser9, iNOS, and PLCA1; and 4) percentage of reduction between 40% and 60% at 8 hours: Mek 1, P-MAPK/ERK 44, AKT-P, TrkB, and PLCA1.
Interlaboratory Variations
Some experiments were carried out in parallel in other laboratories using similar protocols although with individual variations. Four proteins were validated in these studies: A-actin, AKT-P, Cam kinase II, and >-tubulin. Similar results were obtained for the various paradigms in the different laboratories.
Two-Dimensional Gel Electrophoresis, Silver Staining Detection, In-Gel Digestion, and Mass Spectrometry Analysis Two-dimensional gels of frontal homogenates of case 2 stored at 1-C for different time periods up to 50 hours postmortem and then frozen at j80-C were stained with silver. Under these specific conditions, no differences were seen in the number and quality of the silver spots at 2 hours 15 minutes, 5, 8, 23 , and 50 hours (data not shown). In contrast, 2-dimensional gels of frontal homogenates of case 1 stored at 4-C for different time periods up to 50 hours and then frozen at j80-C disclosed marked differences in the silver staining of several spots. Interestingly, several spots progressively decreased in intensity until disappearance at the time point of 50 hours. Yet, other silver spots did not show differences in the intensity of staining (Fig. 3A, B) .
Several spots at 2 hours 15 minutes and 50 hours were in-gel-digested and analyzed by mass spectrometry. The proteins resistant to postmortem delay were YWHAZ, G3PDH, malate dehydrogenase, and aldolase A. Several proteins were vulnerable to postmortem delay, including >-synuclein, A-synuclein, peroxiredoxin, ATP synthase, and superoxide dismutase 1 ( Fig. 3C; Table 2 ). A semiquantitative study of selected proteins that are degraded with time is presented in Table 3 , in which the percentage of reduction is expressed as a percentage of reduced density values in relation with a control protein (aldolase A), which is more stable during the period of the study.
Two-dimensional gels of frontal homogenates in case 4 in which samples were stored at room temperature (22-C) and then frozen disclosed several differences when comparing gels of 2 hours and 48 hours. Several proteins were identified as vulnerable to postmortem delay, including >-synuclein, A-synuclein, vacuolar proton ATPase, fructose-biphosphate aldolase C, amphiphysin, and >-enolase ( Fig. 4 ; Table 4 ). Other proteins, dihydropyrimidinase-like 2, manganese superoxide dismutase, G3PDH, 14-3-3, HSP90, and HSPgp96, were resistant. A semiquantitative study of selected proteins that are degraded with time is presented in Table 5 , in which the percentage of reduction is expressed as a percentage of reduced density values in relation with a control protein (protein 14-3-3), which is more stable in these experimental circumstances during the period of the study.
Posttranslational Modifications in Alzheimer Disease: Phospho-tau Pattern in Sarkosyl-Insoluble Fractions
Blots of AD samples at 2 hours stored at 4-C revealed 3 bands of 68, 64, and 60 kDa, several bands between 60 kDa and 24 kDa, and a band of approximately 22 kDa for up to 26 hours in one case, but the phospho-tau bands were markedly decreased at the same time period in another case. Phosphotau degradation, as revealed by reduction or near disappearance of the bands, was observed at 50 hours postmortem (Fig. 5A,  B) . More marked and rapid degradation was seen in samples obtained at 6 hours and stored at room temperature for different time periods when compared with the same tissue frozen at 6 hours after death (Fig. 5C) . Interestingly, the lower bands were barely visible in this condition. Finally, poor Aldolase A (optical density arbitrarily considered as 100%) is chosen because its preservation was good up to 50 hours postmortem. Numbers in the table express the percentage of optical density when compared with the optical density of aldolase at every time point. Densitometric measurements were obtained by drawing a monodimensional transect across the spot and measuring the optical density along the transect. results were found in samples obtained at 8 hours after death (with the corpse maintained at room temperature) and then frozen. Moreover, no signal was seen in thawed samples further maintained at room temperature for variable periods and then frozen until use (Fig. 5D) .
DISCUSSION
This study was designed to learn the effects of delay and temperature during the postmortem period in human brain tissue. Other factors such as premortem metabolic status and agonal state were minimized in the present study. The pH of the tissues was neutral at the first time postmortem; thus, further indicating no major metabolic disturbances related with prolonged hypoxia and acidosis before death.
By using monodimensional gel electrophoresis and Western blotting to selected proteins, the present results support the concept that postmortem delay can affect protein levels by selective decay of vulnerable proteins. Score coverage: MOWSE scores greater than 48 are considered to offer high confidence of identification. Number of peptides indicates the number of peptides used to identify the protein.
Moreover, reduced temperature during the postmortem period is vital for protein preservation. Although the number of assays was limited, similar observations were obtained in the several laboratories participating in this study, thus indicating that the present observations are applicable to different settings. 
